<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">341</article-id><article-id pub-id-type="doi">10.25208/0042-4609-2017-93-5-47-51</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SHORT COMMUNICATION</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Purulent Hidradenitis. Part I</article-title><trans-title-group xml:lang="ru"><trans-title>Гнойный гидраденит. Часть I</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rodionov</surname><given-names>A. N.</given-names></name><name xml:lang="ru"><surname>Родионов</surname><given-names>А. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Piskarevsky prospect, 47, 195067</p></bio><bio xml:lang="ru"><p>195067, Пискаревский пр., д. 47</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Skrek</surname><given-names>S. V.</given-names></name><name xml:lang="ru"><surname>Скрек</surname><given-names>С. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Piskarevsky prospect, 47, 195067</p><p>Ryleeva str., 24, 191123</p></bio><bio xml:lang="ru"><p>195067, Пискаревский пр., д. 47 </p><p>191123, ул. Рылеева, д. 24 </p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sobolev</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Соболев</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Santiago de Cuba str., 1/28, 194291</p></bio><bio xml:lang="ru"><p>194291, ул. Сантьяго-де-Куба, д. 1/28</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Yunovidova</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Юновидова</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Ryleeva str., 24, 191123</p></bio><bio xml:lang="ru"><p>191123, ул. Рылеева, д. 24</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chernova</surname><given-names>L. R.</given-names></name><name xml:lang="ru"><surname>Чернова</surname><given-names>Л. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Ryleeva str., 24, 191123</p></bio><bio xml:lang="ru"><p>191123, ул. Рылеева, д. 24</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Wolkenstein</surname><given-names>P.</given-names></name><name xml:lang="ru"><surname>Волькенштейн</surname><given-names>П.</given-names></name></name-alternatives><address><country country="FR">France</country></address><bio xml:lang="en"><p>Avenue du Maréchal de Lattre de Tassigny, 51, 94000</p></bio><bio xml:lang="ru"><p>94000, ул. du Maréchal de Lattre de Tassigny, д. 51</p></bio><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of Russian Federation, St. Petersburg</institution></aff><aff><institution xml:lang="ru">Cеверо-Западный государственный медицинский университет им. И. И. Мечникова Минздрава России, г. Санкт-Петербург</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">The Pierre Wolkenstein French Dermatological Clinic, St. Petersburg</institution></aff><aff><institution xml:lang="ru">Клиника кожных болезней Пьера Волькенштейна, г. Санкт-Петербург,</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Research Institute of Medical Mycology named after P. N. Kashkin, North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of Russian Federation, St. Petersburg</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт медицинской микологии им. П. Н. Кашкина Северо-Западного государственного медицинского университета им. И. И. Мечникова Минздрава России, г. Санкт-Петербург</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Dermatological Service of the Henri Mondor University Hospital, Créteil</institution></aff><aff><institution xml:lang="ru">Дерматологическая служба университетского госпиталя Энри Мондор, Кретей</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-10-04" publication-format="electronic"><day>04</day><month>10</month><year>2017</year></pub-date><volume>93</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>47</fpage><lpage>51</lpage><history><date date-type="received" iso-8601-date="2018-01-04"><day>04</day><month>01</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-01-04"><day>04</day><month>01</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Rodionov A.N., Skrek S.V., Sobolev A.V., Yunovidova A.A., Chernova L.R., Wolkenstein P.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, Родионов А.Н., Скрек С.В., Соболев А.В., Юновидова А.А., Чернова Л.Р., Волькенштейн П.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Rodionov A.N., Skrek S.V., Sobolev A.V., Yunovidova A.A., Chernova L.R., Wolkenstein P.</copyright-holder><copyright-holder xml:lang="ru">Родионов А.Н., Скрек С.В., Соболев А.В., Юновидова А.А., Чернова Л.Р., Волькенштейн П.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/341">https://vestnikdv.ru/jour/article/view/341</self-uri><abstract xml:lang="en"><p>Until recently, the pathogenesis of purulent hidradenitis was a little- and sporadically studied issue, which invariably created difficulties in the therapeutic treatment of this disease. Its often severe recurrency rate, high incidence and the lack of effective treatment have predetermined the urgency of the problem and raised the scientific and practical interest in this field among the scientists worldwide. Recent data indicate a significant role of damage-associated molecular patterns (DAMP) and the activation of congenital immunity, associated with Th17 lymphocytes, in the development of inflammatory disease. Likewise, the violation of the transmission of the cellular Notch signaling pathway plays an important role in the development of purulent hidradenitis. </p></abstract><trans-abstract xml:lang="ru"><p>До недавнего времени патогенез гнойного гидраденита являлся малоизученной и нерешенной проблемой, что неизменно создавало трудности в терапии этого заболевания. Зачастую тяжелое рецидивирующее течение, высокая частота встречаемости и отсутствие эффективного лечения предопределили актуальность проблемы и обусловили научно-практический интерес ученых всего мира в этой области. Последние данные свидетельствуют о существенной роли в развитии заболевания воспалительных молекул DAMP и активации врожденного иммунитета, связанного с Тh17-лимфоцитами. Немаловажную роль в развитии гнойного гидраденита также играет нарушение передачи клеточного сигнала Notch-пути. </p></trans-abstract><kwd-group xml:lang="en"><kwd>purulent hidradenitis</kwd><kwd>Notch signaling pathway</kwd><kwd>Th17 cells</kwd><kwd>urulent hidradenitis</kwd><kwd>Notch signaling pathway</kwd><kwd>Th17 cells</kwd><kwd>Ȗ-secretase secretase</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гнойный гидраденит</kwd><kwd>Notch-путь</kwd><kwd>Th17-клетки</kwd><kwd>нойный гидраденит</kwd><kwd>Notch-путь</kwd><kwd>Th17-клетки</kwd><kwd>Ȗ-секретаза</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Dufour D. N., Emtestam L., Jemec G. B. Hidradenitis Suppurativa: a Common and Burdensome, Yet Under-recognised, Inflammatory Skin Disease. Postgrad. Med. J. 2014;90(1062):216–221.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Jemec G. Hidradenitis Suppurativa. N. Engl. J. Med. 2012;366(2):158–164.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Schlapbach C., Ha¨nni T., Yawalkar N., Hunger R. E. Expression of the IL-23/Th17 Pathway in Lesions of Hidradenitis Suppurativa. J. Am. Acad. Dermatol. 2011;65(4):790–798.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. van der Zee H. H., de Ruiter L., van den Broecke D. G. et al. Elevated Levels of Tumour Necrosis Factor (TNF)-Į, Interleukin (IL)-1ȕ and IL-10 in Hidradenitis Suppurativa Skin: a Rationale for Targeting TNF-Į and IL-1ȕ. Br. J. Dermatol. 2011;164(6):1292–1298.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Rangarajan A., Talora C., Okuyama R. et al. Notch Signaling is a Direct Determinant of Keratinocyte Growth Arrest and Entry into Differentiation. EMBO J. 2001;20(13):3427–3436.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Pan Y., Lin M. H., Tian X. et al. Gamma-Secretase Functions through Notch Signaling to Maintain Skin Appendages but is not Required for Their Patterning or Initial Morphogenesis. Dev. Cell. 2004;7(5):731–743.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Velpeau A. Dictionnaire de Médecine, un Repertoire Général des Sciences Médicales. 2nd éd. Paris: Bechet jeune, 1839–1845. Vol. 2. P. 91; Vol. 3. P. 304; Vol. 19. P. 1.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Verneuil A. E`tudes sur les Tumeurs de la Peau et Quelques Maladies des Glandes Sudoripares. Arch. Gen. Med. 1854;4:447–468, 693– 704.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Plewig G., Kligman A. M. Acne: Morphogenesis and Treatment. Berlin: Springer-Verlag, 1975. P. 192–193.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Selkoe D., Kopan R. Notch and Presenilin: Regulated Intramembrane Proteolysis Links Development and Degeneration. Annu. Rev. Neurosci. 2003:26:565–597.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Kwon S. M., Alev C., Lee S. H., Asahara T. The Molecular Basis of Notch Signaling: a Brief Overview. Adv. Exp. Med. Biol. 2012:727:1–14.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. von Laffert M., Helmbold P., Wohlrab J. et al. Hidradenitis Suppurativa (Acne Inversa): Early Inflammatory Events at Terminal Follicles and at Interfollicular Epidermis. Exp. Dermatol. 2010;19(6):533–537.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Fismen S., Ingvarsson G., Moseng D. et al. A Clinical-Pathological Review of Hidradenitis Suppurativa: Using Immunohistochemistry One Disease Becomes Two. APMIS. 2012;120(6):433–440.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Okuyama R., Tagami H., Aiba S. Notch Signaling: Its Role in Epidermal Homeostasis and in the Pathogenesis of Skin Diseases. J. Dermatol. Sci. 2008:49(3):187–194.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Yuan J. S., Kousis P. C., Suliman S. et al. Functions of Notch Signaling in the Immune System: Consensus and Controversies. Annu. Rev. Immunol. 2010:28:343–365.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Auderset F., Coutaz M., Tacchini-Cottier F. The Role of Notch in the Differentiation of CD4+ T Helper Cells. Curr. Top. Microbiol. Immunol. 2012:360:115–134.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. Zhang Q., Wang C., Liu Z. et al. Notch Signal Suppresses Tolllike Receptor-triggered Inflammatory Responses in Macrophages by Inhibiting Extracellular Signal-regulated Kinase 1/2-mediated Nuclear Factor țB Activation. J. Biol. Chem. 2012:287(9):6208–6217.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. Melnik B. C., Plewig G. Impaired Notch Signalling: the Unifying Mechanism Explaining the Pathogenesis of Hidradenitis Suppurativa (Acne Inversa). Br. J. Dermatol. 2013;168(4):876–878.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Wakura Y., Ishigame H., Saijo S., Nakae S. Functional Specialization of Interleukin-17 Family Members. Immunity. 2011:34(2):149– 162.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Hunger R. E., Surovy A. M., Hassan A. S. et al. Toll-Like Receptor 2 Is Highly Expressed in Lesions of Acne Inversa and Colocalizes With C-Type Lectin Receptor. Br. J. Dermatol. 2008:158(4):691–697.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Wang X., Liu Y. Regulation of Innate Immune Response by MAP Kinase Phosphatase-1. Cell. Signal. 2007;19(7):1372–1382.</mixed-citation></ref></ref-list></back></article>
